NAPROSYN Side Effects

6921361-5 | Urticaria, Vision Blurred
on Jul 07, 2010 Female patient from UNITED STATES , 91 years of age, was treated with Naprosyn (View Usage). Patient experienced the following unwanted or unexpected effects: urticaria, vision blurred. Naprosyn dosage: .

6921360-3 | Eye Swelling
Patient was taking Naprosyn (View Usage). Patient had the following side effects: eye swelling on Jul 07, 2010 from UNITED STATES Additional patient health information: Female patient , 53 years of age, . Naprosyn dosage: .

6905875-X | Gangrene, Leukocytoclastic Vasculitis, Peripheral Ischaemia
Adverse event was reported on Jul 22, 2010 by a Female patient taking Naprosyn (View Usage) (Dosage: ) was diagnosed with chest pain (What is chest pain?) and. Location: GERMANY , 33 years of age, After Naprosyn was administered, patient had the following side effects: gangrene, leukocytoclastic vasculitis, peripheral ischaemia. During the same period patient was treated with PROPOXYPHENE HCL (View Propoxyphene Hcl Review and Propoxyphene Hcl Label ), DARVOCET (View Darvocet Review and Darvocet Label ), NITROGLYCERIN (View Nitroglycerin Review and Nitroglycerin Label ), ROCEPHIN (View Rocephin Review and Rocephin Label ), CIPROFLOXACIN (View Ciprofloxacin Review and Ciprofloxacin Label ), CYTOXAN (View Cytoxan Review and Cytoxan Label ), BACTRIM (View Bactrim Review and Bactrim Label ). Patient was hospitalized and became disabled.

6877055-8 | Gangrene, Leukocytoclastic Vasculitis, Peripheral Ischaemia
on Jul 13, 2010 Female patient from GERMANY , 33 years of age, was diagnosed with chest pain (What is chest pain?) and was treated with Naprosyn (View Usage). Patient experienced the following unwanted or unexpected effects: gangrene, leukocytoclastic vasculitis, peripheral ischaemia. Naprosyn dosage: . During the same period patient was treated with PROPOXYPHENE HCL (View Propoxyphene Hcl Review and Propoxyphene Hcl Label ), DARVOCET (View Darvocet Review and Darvocet Label ), NITROGLYCERIN (View Nitroglycerin Review and Nitroglycerin Label ), ROCEPHIN (View Rocephin Review and Rocephin Label ), CIPROFLOXACIN (View Ciprofloxacin Review and Ciprofloxacin Label ), CYTOXAN (View Cytoxan Review and Cytoxan Label ), BACTRIM (View Bactrim Review and Bactrim Label ). Patient was hospitalized and became disabled.


6831950-4 | Convulsion Neonatal, Microcephaly, Oxygen Saturation Decreased, Respiratory Distress
on May 03, 2010 Male patient from GERMANY , weighting 6.17 lb, was treated with Naprosyn (View Usage). Patient had the following side effects: convulsion neonatal, microcephaly, oxygen saturation decreased, respiratory distress. Naprosyn dosage: . During the same period patient was treated with IBUPROFENE (View Ibuprofene Review and Ibuprofene Label ).

6756320-9 | Anxiety, Rheumatoid Factor Increased, Suicidal Ideation
Patient was taking Naprosyn (View Usage). After Naprosyn was administered, patient had the following side effects: anxiety (What is anxiety?), rheumatoid factor increased, suicidal ideation on May 25, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 143.3 lb, was diagnosed with fibromyalgia, depression (What is depression?), hypertension, hysterectomy (What is hysterectomy?) and. Naprosyn dosage: Hard Capsule. During the same period patient was treated with LYRICA (View Lyrica Review and Lyrica Label ), NEURONTIN (View Neurontin Review and Neurontin Label ), CYMBALTA (View Cymbalta Review and Cymbalta Label ), ZOLOFT (View Zoloft Review and Zoloft Label ), DIOVAN (View Diovan Review and Diovan Label ), PREMARIN (View Premarin Review and Premarin Label ), AMBIEN (Daily) (View Ambien Review and Ambien Label ).

6749222-5 | Nausea
Adverse event was reported on May 01, 2010 by a Female patient taking Naprosyn (View Usage) (Dosage: ) was diagnosed with pain (What is pain?) and. Location: UNITED STATES , 51 years of age, Patient experienced the following unwanted or unexpected effects: nausea (What is nausea?). During the same period patient was treated with VICODIN (View Vicodin Review and Vicodin Label ).

6729880-1 | Burning Sensation, Pain, Pruritus
on Apr 15, 2010 Female patient from UNITED STATES , 76 years of age, was treated with Naprosyn (View Usage). Patient had the following side effects: burning sensation, pain (What is pain?), pruritus. Naprosyn dosage: .

6721816-2 | Convulsion Neonatal, Microcephaly, Oxygen Saturation Decreased, Respiratory Distress
on May 03, 2010 Male patient from GERMANY , weighting 6.17 lb, was treated with Naprosyn (View Usage). After Naprosyn was administered, patient had the following side effects: convulsion neonatal, microcephaly, oxygen saturation decreased, respiratory distress. Naprosyn dosage: . During the same period patient was treated with IBUPROFENE (View Ibuprofene Review and Ibuprofene Label ).

6542977-4 | Gastrointestinal Haemorrhage, Muscle Spasms, Neuropathy Peripheral, Renal Disorder, Weight Decreased
Patient was taking Naprosyn (View Usage). Patient experienced the following unwanted or unexpected effects: gastrointestinal haemorrhage, muscle spasms, neuropathy peripheral, renal disorder, weight decreased on Jan 15, 2010 from UNITED STATES Additional patient health information: Female patient , 68 years of age, . Naprosyn dosage: Frequency: Three Times Daily Or Four Times Daily.. During the same period patient was treated with LASIX (View Lasix Review and Lasix Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), LIBRIUM (View Librium Review and Librium Label ), PRAVACHOL (View Pravachol Review and Pravachol Label ), OXYCODONE (View Oxycodone Review and Oxycodone Label ), VITAMIN B 12 (View Vitamin B-12 Review and Vitamin B-12 Label ).

6490215-3 | Cholecystectomy, Duodenal Ulcer Perforation
Adverse event was reported on Dec 09, 2009 by a Male patient taking Naprosyn (View Usage) (Dosage: ) . Location: UNITED STATES , 53 years of age, weighting 175.3 lb, Patient had the following side effects: cholecystectomy, duodenal ulcer perforation.

6430244-9 | Cough, Interstitial Lung Disease, Lung Disorder, Pyrexia
on Oct 29, 2009 Male patient from UNITED STATES , weighting 147.0 lb, was diagnosed with hepatitis c (What is hepatitis c?) and was treated with Naprosyn (View Usage). After Naprosyn was administered, patient had the following side effects: cough, interstitial lung disease, lung disorder, pyrexia. Naprosyn dosage: . During the same period patient was treated with PEGASYS (View Pegasys Review and Pegasys Label ), RIBAVIRIN (Dose: 400 Mg At Am And 600 Mg At Pm) (View Ribavirin Review and Ribavirin Label ), WELLBUTRIN (View Wellbutrin Review and Wellbutrin Label ).

6406878-4 | Anaemia, Haematoma
on Oct 08, 2009 Female patient from GERMANY , 62 years of age, was treated with Naprosyn (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia, haematoma. Naprosyn dosage: . During the same period patient was treated with PREVISCAN (More Than One Dose Form Daily) (View Previscan Review and Previscan Label ), INNOHEP (View Innohep Review and Innohep Label ). Patient was hospitalized.

6366487-2 | Leukocytoclastic Vasculitis
Patient was taking Naprosyn (View Usage). Patient had the following side effects: leukocytoclastic vasculitis on Sep 11, 2009 from GERMANY Additional patient health information: Male patient , weighting 202.8 lb, . Naprosyn dosage: Frequency: 2 Tablets Daily. Patient was hospitalized.

6317581-3 | Dyspepsia, Gastric Ulcer, Gastrooesophageal Reflux Disease
Adverse event was reported on Aug 18, 2009 by a Female patient taking Naprosyn (View Usage) (Dosage: ) . Location: CANADA , 39 years of age, After Naprosyn was administered, patient had the following side effects: dyspepsia, gastric ulcer, gastrooesophageal reflux disease.

6316854-8 | Anaemia, Gastrointestinal Disorder
on Aug 18, 2009 Male patient from CANADA , child 6 years of age, was treated with Naprosyn (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia, gastrointestinal disorder. Naprosyn dosage: Received For Three Months.

6292284-2 | Hallucination, Nightmare
on Jul 30, 2009 Female patient from UNITED STATES , weighting 193.0 lb, was diagnosed with osteoarthritis (What is osteoarthritis?) and was treated with Naprosyn (View Usage). Patient had the following side effects: hallucination, nightmare. Naprosyn dosage: 500 Mg Bid Po.

6291632-7 | Alopecia
Patient was taking Naprosyn (View Usage). After Naprosyn was administered, patient had the following side effects: alopecia on Jul 30, 2009 from UNITED STATES Additional patient health information: Female patient , 47 years of age, weighting 120.0 lb, was diagnosed with pain (What is pain?) and. Naprosyn dosage: 500 Mg, Bid, Po.

6271431-2 | Asthenia, Confusional State, Disorientation, Dysarthria, Facial Paresis, Mental Status Changes, Pyuria, Renal Failure Acute, Urinary Retention
Adverse event was reported on Jul 07, 2009 by a Female patient taking Naprosyn (View Usage) (Dosage: ) . Location: UNITED KINGDOM , 85 years of age, Patient experienced the following unwanted or unexpected effects: asthenia, confusional state, disorientation, dysarthria, facial paresis, mental status changes, pyuria, renal failure acute, urinary retention. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), NIFEDIPINE (View Nifedipine Review and Nifedipine Label ), INDOMETHACIN (View Indomethacin Review and Indomethacin Label ), ELAVIL (Tapered And Withdrawn) (View Elavil Review and Elavil Label ), BUSPAR (View Buspar Review and Buspar Label ), REMERON (View Remeron Review and Remeron Label ), LIBRAX (Tapered And Withdrawn) (View Librax Review and Librax Label ), PERPHENAZINE (Tapered And Withdrawn) (View Perphenazine Review and Perphenazine Label ). Patient was hospitalized.

6266962-5 | Mental Status Changes, Renal Failure Acute, Urinary Tract Infection
on Jul 07, 2009 Female patient from GERMANY , 85 years of age, was treated with Naprosyn (View Usage). Patient had the following side effects: mental status changes, renal failure acute, urinary tract infection (What is urinary tract infection?). Naprosyn dosage: . During the same period patient was treated with NIFEDIPINE (View Nifedipine Review and Nifedipine Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), INDOMETHACIN (View Indomethacin Review and Indomethacin Label ), ELAVIL (Tapered And Withdrawn) (View Elavil Review and Elavil Label ), BUSPAR (View Buspar Review and Buspar Label ), REMERON (View Remeron Review and Remeron Label ), LIBRAX (Tapered And Withdrawn) (View Librax Review and Librax Label ), PERPHENAZINE (Tapered And Withdrawn) (View Perphenazine Review and Perphenazine Label ). Patient was hospitalized.

6247067-6 | Duodenal Ulcer, Haemoglobin Decreased, Melaena
on Jun 24, 2009 Female patient from UNITED STATES , 93 years of age, weighting 125.7 lb, was diagnosed with arthritis (What is arthritis?), atrial fibrillation (What is atrial fibrillation?) and was treated with Naprosyn (View Usage). After Naprosyn was administered, patient had the following side effects: duodenal ulcer, haemoglobin decreased, melaena. Naprosyn dosage: 220mg Po Bid. During the same period patient was treated with WARFARIN SODIUM (2mg Po Qd) (View Warfarin Sodium Review and Warfarin Sodium Label ), CITALOPRAM HYDROBROMIDE (View Citalopram Hydrobromide Review and Citalopram Hydrobromide Label ), LORATADINE (View Loratadine Review and Loratadine Label ), DILTIAZEM (View Diltiazem Review and Diltiazem Label ), M.V.I. (View M.v.i. Review and M.v.i. Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), TUMS (View Tums Review and Tums Label ), ENALAPRIL (View Enalapril Review and Enalapril Label ). Patient was hospitalized.

6204052-8 | Alopecia, Thinking Abnormal, Thyroid Disorder, Tinnitus
Patient was taking Naprosyn (View Usage). Patient experienced the following unwanted or unexpected effects: alopecia, thinking abnormal, thyroid disorder, tinnitus (What is tinnitus?) on May 26, 2009 from UNITED STATES Additional patient health information: Female patient , 57 years of age, weighting 127.0 lb, was diagnosed with neuralgia and. Naprosyn dosage: 2700mg.

6187175-1 | Blood Pressure Decreased, Flushing, Headache, Hypersensitivity
Adverse event was reported on Jan 13, 2009 by a Female patient taking Naprosyn (View Usage) (Dosage: ) . Location: UNITED STATES , 62 years of age, Patient had the following side effects: blood pressure decreased, flushing, headache (What is headache?), hypersensitivity.

6187174-X | Gastric Ulcer Perforation
on Jan 13, 2009 Male patient from UNITED STATES , 54 years of age, weighting 136.9 lb, was diagnosed with back pain (What is back pain?) and was treated with Naprosyn (View Usage). After Naprosyn was administered, patient had the following side effects: gastric ulcer perforation. Naprosyn dosage: 500 Mg 2 Per Day Oral. During the same period patient was treated with PREDNISONE TAB (View Prednisone Tab Review and Prednisone Tab Label ). Patient was hospitalized.

6187173-8 | Anastomotic Haemorrhage, Large Intestinal Haemorrhage
on Nov 19, 2008 Male patient from UNITED STATES , 74 years of age, was treated with Naprosyn (View Usage). Patient experienced the following unwanted or unexpected effects: anastomotic haemorrhage, large intestinal haemorrhage. Naprosyn dosage: . Patient was hospitalized.

6187165-9 | Gastric Polyps, Gastric Ulcer
Patient was taking Naprosyn (View Usage). Patient had the following side effects: gastric polyps, gastric ulcer on Oct 08, 2008 from UNITED STATES Additional patient health information: Female patient , 67 years of age, . Naprosyn dosage: . During the same period patient was treated with TYLENOL (View Tylenol Review and Tylenol Label ).

6187164-7 | Gastric Ulcer, Gastrooesophageal Reflux Disease, Nausea
Adverse event was reported on Feb 26, 2009 by a Female patient taking Naprosyn (View Usage) (Dosage: ) was diagnosed with inflammation, pain (What is pain?), intervertebral disc protrusion and. Location: UNITED STATES , 60 years of age, After Naprosyn was administered, patient had the following side effects: gastric ulcer, gastrooesophageal reflux disease, nausea (What is nausea?). During the same period patient was treated with ALEVE (660 Mg 3 Per 1 Day) (View Aleve Review and Aleve Label ), BUSPAR (View Buspar Review and Buspar Label ), PROVIGIL (View Provigil Review and Provigil Label ), STRATTERA (View Strattera Review and Strattera Label ), PERIACTIN (View Periactin Review and Periactin Label ), PROMETRIUM (View Prometrium Review and Prometrium Label ), VIVELLE DOT (View Vivelle-dot Review and Vivelle-dot Label ).

6187152-0 | Ecchymosis, Purpura
on Mar 04, 2009 Male patient from UNITED STATES , 68 years of age, was diagnosed with back pain (What is back pain?) and was treated with Naprosyn (View Usage). Patient experienced the following unwanted or unexpected effects: ecchymosis, purpura. Naprosyn dosage: 3000 Mg Daily. During the same period patient was treated with COUMADIN (View Coumadin Review and Coumadin Label ).

6170410-3 | Rash
on Apr 27, 2009 Female patient from UNITED STATES , weighting 361.6 lb, was treated with Naprosyn (View Usage). Patient had the following side effects: rash (What is rash?). Naprosyn dosage: 500mg Tablet 500 Mg Bid Oral. During the same period patient was treated with BENADRYL (View Benadryl Review and Benadryl Label ), CELEXA (View Celexa Review and Celexa Label ), CLARITIN D (View Claritin-d Review and Claritin-d Label ), EPIPEN (View Epipen Review and Epipen Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ), MAALOX (View Maalox Review and Maalox Label ), METHYLPREDNISOLONE 4MG TAB (View Methylprednisolone 4mg Tab Review and Methylprednisolone 4mg Tab Label ), PERCOCET (View Percocet Review and Percocet Label ).

6168015-3 | Diverticular Perforation
Patient was taking Naprosyn (View Usage). After Naprosyn was administered, patient had the following side effects: diverticular perforation on Apr 22, 2009 from FRANCE Additional patient health information: Female patient , weighting 140.0 lb, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Naprosyn dosage: . During the same period patient was treated with MABTHERA (View Mabthera Review and Mabthera Label ), SOLU MEDROL (View Solu-medrol Review and Solu-medrol Label ), METHOTREXATE (View Methotrexate Review and Methotrexate Label ), CORTANCYL (View Cortancyl Review and Cortancyl Label ), ACETAMINOPHEN AND CODEINE PHOSPHATE (View Acetaminophen And Codeine Phosphate Review and Acetaminophen And Codeine Phosphate Label ). Patient was hospitalized.

6160839-1 | Gastrointestinal Perforation
Adverse event was reported on Apr 09, 2009 by a Female patient taking Naprosyn (View Usage) (Dosage: ) was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Location: FRANCE , weighting 140.0 lb, Patient experienced the following unwanted or unexpected effects: gastrointestinal perforation. During the same period patient was treated with MABTHERA (View Mabthera Review and Mabthera Label ), SOLU MEDROL (View Solu-medrol Review and Solu-medrol Label ), ACETAMINOPHEN AND CODEINE PHOSPHATE (View Acetaminophen And Codeine Phosphate Review and Acetaminophen And Codeine Phosphate Label ), CORTANCYL (View Cortancyl Review and Cortancyl Label ). Patient was hospitalized.

6151553-7 | Blood Alkaline Phosphatase Increased, Blood Urea Increased, Constipation, Haemoglobin Decreased, Intestinal Dilatation, Platelet Count Increased, Pyrexia, White Blood Cell Count Increased
on Apr 08, 2009 Male patient from UNITED STATES , weighting 108.0 lb, was treated with Naprosyn (View Usage). Patient had the following side effects: blood alkaline phosphatase increased, blood urea increased, constipation (What is constipation?), haemoglobin decreased, intestinal dilatation, platelet count increased, pyrexia, white blood cell count increased. Naprosyn dosage: . During the same period patient was treated with TRAMADOL (View Tramadol Review and Tramadol Label ), MARAVIROC (View Maraviroc Review and Maraviroc Label ), DICLOFENAC SODIUM (View Diclofenac Sodium Review and Diclofenac Sodium Label ), RALTEGRAVIR (View Raltegravir Review and Raltegravir Label ), ATAZANAVIR SULFATE (View Atazanavir Sulfate Review and Atazanavir Sulfate Label ), AMITRIPTYLINE HCL (View Amitriptyline Hcl Review and Amitriptyline Hcl Label ), CLOTRIMAZOLE (View Clotrimazole Review and Clotrimazole Label ), VITAMIN K (View Vitamin K Review and Vitamin K Label ). Patient was hospitalized.

6119265-3 | Duodenal Ulcer Haemorrhage
on Mar 06, 2009 Female patient from UNITED STATES , weighting 156.5 lb, was diagnosed with arthritis (What is arthritis?), type 2 diabetes mellitus and was treated with Naprosyn (View Usage). After Naprosyn was administered, patient had the following side effects: duodenal ulcer haemorrhage. Naprosyn dosage: . During the same period patient was treated with HUMAN INSULIN (View Human Insulin Review and Human Insulin Label ), ISOPHANE INSULIN (36 Units Qam) (View Isophane Insulin Review and Isophane Insulin Label ), LIPITOR (View Lipitor Review and Lipitor Label ), TRICOR (View Tricor Review and Tricor Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ). Patient was hospitalized.

6060407-6 | Gastrointestinal Disorder
Patient was taking Naprosyn (View Usage). Patient experienced the following unwanted or unexpected effects: gastrointestinal disorder on Jan 29, 2009 from UNITED STATES Additional patient health information: Female patient , weighting 134.3 lb, . Naprosyn dosage: 500 Mg Tablet 500 Mg Bid Oral. During the same period patient was treated with CALCIUM + D (500 ELEM.CA) (CALCIUM CARBONATE 1250 MG (500MG ELEM CA/ V (View Calcium + D (500 Elem.ca) (calcium Carbonate 1250 Mg (500mg Elem Ca/ V Review and Calcium + D (500 Elem.ca) (calcium Carbonate 1250 Mg (500mg Elem Ca/ V Label ), MULTIVITAMIN THERAPEUTIC (THERAPEUTIC MULTIVITAMINS) (View Multivitamin Therapeutic (therapeutic Multivitamins) Review and Multivitamin Therapeutic (therapeutic Multivitamins) Label ), OMEGA 3 FATTY ACIDS (View Omega 3 Fatty Acids Review and Omega 3 Fatty Acids Label ).

6045004-0 | Burning Sensation, Eye Irritation, Eye Pruritus
Adverse event was reported on Jan 16, 2009 by a Male patient taking Naprosyn (View Usage) (Dosage: 500 Mg Once Po Bid) was diagnosed with back pain (What is back pain?) and. Location: UNITED STATES , 23 years of age, weighting 197.0 lb, Patient had the following side effects: burning sensation, eye irritation, eye pruritus.

6011428-0 | Dehydration, Depression, Duodenal Ulcer, Ecchymosis, Hiatus Hernia, Musculoskeletal Pain, Parkinson's Disease, Pneumonia
on Aug 29, 2000 Female patient from UNITED STATES , weighting 127.0 lb, was diagnosed with pain (What is pain?) and was treated with Naprosyn (View Usage). After Naprosyn was administered, patient had the following side effects: dehydration, depression (What is depression?), duodenal ulcer, ecchymosis, hiatus hernia, musculoskeletal pain, parkinson's disease (What is parkinson's disease?), pneumonia (What is pneumonia?). Naprosyn dosage: . During the same period patient was treated with RISPERDAL (View Risperdal Review and Risperdal Label ), DURAGESIC 100 (View Duragesic-100 Review and Duragesic-100 Label ), IBUPROFEN (View Ibuprofen Review and Ibuprofen Label ), PREDNISONE TAB (View Prednisone Tab Review and Prednisone Tab Label ), TYLENOL (CAPLET) (View Tylenol (caplet) Review and Tylenol (caplet) Label ), CLARITIN (View Claritin Review and Claritin Label ), SINEMET (View Sinemet Review and Sinemet Label ). Patient was hospitalized.

5991419-6 | Blood Pressure Systolic Decreased, Faeces Discoloured
on Dec 01, 2008 Female patient from GERMANY , 75 years of age, was diagnosed with spondylitis, back pain (What is back pain?) and was treated with Naprosyn (View Usage). Patient experienced the following unwanted or unexpected effects: blood pressure systolic decreased, faeces discoloured. Naprosyn dosage: . During the same period patient was treated with ALEVE (View Aleve Review and Aleve Label ), CLONIDINE (View Clonidine Review and Clonidine Label ), NIFEDIPINE (View Nifedipine Review and Nifedipine Label ).

5968110-5 | No Adverse Event, Overdose, Suicide Attempt
Patient was taking Naprosyn (View Usage). Patient had the following side effects: no adverse event, overdose, suicide attempt on Nov 19, 2008 from UNITED STATES Additional patient health information: Female patient , 40 years of age, . Naprosyn dosage: . During the same period patient was treated with ACCUTANE (View Accutane Review and Accutane Label ), DULOXETINE (View Duloxetine Review and Duloxetine Label ), CETIRIZINE HYDROCHLORIDE (View Cetirizine Hydrochloride Review and Cetirizine Hydrochloride Label ), FLUOXETINE HYDROCHLORIDE (View Fluoxetine Hydrochloride Review and Fluoxetine Hydrochloride Label ), RISPERIDONE (View Risperidone Review and Risperidone Label ).

5926664-9 | Arthritis, Leukocytoclastic Vasculitis
Adverse event was reported on Oct 14, 2008 by a Male patient taking Naprosyn (View Usage) (Dosage: ) was diagnosed with ankylosing spondylitis (What is ankylosing spondylitis?), tuberculin test positive, diarrhoea, pain (What is pain?) and. Location: FRANCE , 51 years of age, After Naprosyn was administered, patient had the following side effects: arthritis (What is arthritis?), leukocytoclastic vasculitis. During the same period patient was treated with RIFINAH (View Rifinah Review and Rifinah Label ), IMODIUM (View Imodium Review and Imodium Label ), CRESTOR (View Crestor Review and Crestor Label ), NEXIUM (View Nexium Review and Nexium Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), TRAMADOL HCL (View Tramadol Hcl Review and Tramadol Hcl Label ). Patient was hospitalized.

5900125-5 | Blood Pressure Systolic Decreased, Faeces Discoloured
on Sep 12, 2008 Female patient from GERMANY , 75 years of age, was diagnosed with spondylitis, back pain (What is back pain?) and was treated with Naprosyn (View Usage). Patient experienced the following unwanted or unexpected effects: blood pressure systolic decreased, faeces discoloured. Naprosyn dosage: . During the same period patient was treated with ALEVE (View Aleve Review and Aleve Label ), CLONIDINE (View Clonidine Review and Clonidine Label ), NIFEDIPINE (View Nifedipine Review and Nifedipine Label ).

5895097-6 | Blood Pressure Systolic Decreased, Faeces Discoloured
on Sep 12, 2008 Female patient from GERMANY , 75 years of age, was diagnosed with spondylitis, back pain (What is back pain?) and was treated with Naprosyn (View Usage). Patient had the following side effects: blood pressure systolic decreased, faeces discoloured. Naprosyn dosage: . During the same period patient was treated with ALEVE (View Aleve Review and Aleve Label ).

5874082-4 | Breast Cancer Stage I, Breast Mass
Patient was taking Naprosyn (View Usage). After Naprosyn was administered, patient had the following side effects: breast cancer stage i, breast mass on Sep 03, 2008 from UNITED STATES Additional patient health information: Female patient , weighting 200.0 lb, was diagnosed with multiple sclerosis (What is multiple sclerosis?) and. Naprosyn dosage: . During the same period patient was treated with REBIF (View Rebif Review and Rebif Label ), SYNTHROID (View Synthroid Review and Synthroid Label ), NEURONTIN (View Neurontin Review and Neurontin Label ), CYMBALTA (View Cymbalta Review and Cymbalta Label ).

5859188-8 | Breast Cancer Stage I, Breast Mass
Adverse event was reported on Aug 22, 2008 by a Female patient taking Naprosyn (View Usage) (Dosage: ) was diagnosed with multiple sclerosis (What is multiple sclerosis?) and. Location: UNITED STATES , weighting 200.0 lb, Patient experienced the following unwanted or unexpected effects: breast cancer stage i, breast mass. During the same period patient was treated with REBIF (View Rebif Review and Rebif Label ), SYNTHROID (View Synthroid Review and Synthroid Label ), NEURONTIN (View Neurontin Review and Neurontin Label ), CYMBALTA (View Cymbalta Review and Cymbalta Label ).

5784359-9 | Gastrointestinal Haemorrhage
on Jun 20, 2008 Female patient from UNITED STATES , 58 years of age, weighting 143.3 lb, was treated with Naprosyn (View Usage). Patient had the following side effects: gastrointestinal haemorrhage. Naprosyn dosage: 500mg Tid Po.

5737653-1 | Renal Failure Acute
on Dec 11, 2007 Male patient from UNITED STATES , 52 years of age, was diagnosed with arthralgia, hypertension and was treated with Naprosyn (View Usage). After Naprosyn was administered, patient had the following side effects: renal failure acute. Naprosyn dosage: 800 Mg Daily 400 Per 2 Day. During the same period patient was treated with ENALAPRIL MALEATE (10 Mg Daily) (View Enalapril Maleate Review and Enalapril Maleate Label ), PREDNISONE TAB (View Prednisone Tab Review and Prednisone Tab Label ), ROSIGLITAZONE (View Rosiglitazone Review and Rosiglitazone Label ), FLUTICASONE (FLUTICASONE PROPIONATE) (View Fluticasone (fluticasone Propionate) Review and Fluticasone (fluticasone Propionate) Label ), ALBUTEROL/IPRATROPIUM (IPRATROPIUM SALBUTAMOL) (View Albuterol/ipratropium (ipratropium Salbutamol) Review and Albuterol/ipratropium (ipratropium Salbutamol) Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ). Patient was hospitalized.

5737627-0 | Renal Failure
Patient was taking Naprosyn (View Usage). Patient experienced the following unwanted or unexpected effects: renal failure on Apr 02, 2007 from UNITED STATES Additional patient health information: Female patient , 45 years of age, was diagnosed with multiple sclerosis (What is multiple sclerosis?) and. Naprosyn dosage: . During the same period patient was treated with REBIF (44 Mcg 3 Per Week Subcutaneous) (View Rebif Review and Rebif Label ), ULTRAM (View Ultram Review and Ultram Label ).

5728485-9 | Breast Cancer Stage I, Breast Mass
Adverse event was reported on Apr 29, 2008 by a Female patient taking Naprosyn (View Usage) (Dosage: ) was diagnosed with multiple sclerosis (What is multiple sclerosis?) and. Location: UNITED STATES , weighting 200.0 lb, Patient had the following side effects: breast cancer stage i, breast mass. During the same period patient was treated with REBIF (View Rebif Review and Rebif Label ), SYNTHROID (View Synthroid Review and Synthroid Label ), NEURONTIN (View Neurontin Review and Neurontin Label ), CYMBALTA (View Cymbalta Review and Cymbalta Label ).

5712447-1 | Breast Cancer Stage I, Breast Mass
on Apr 11, 2008 Female patient from UNITED STATES , weighting 200.0 lb, was diagnosed with multiple sclerosis (What is multiple sclerosis?) and was treated with Naprosyn (View Usage). After Naprosyn was administered, patient had the following side effects: breast cancer stage i, breast mass. Naprosyn dosage: . During the same period patient was treated with REBIF (View Rebif Review and Rebif Label ), SYNTHROID (View Synthroid Review and Synthroid Label ), NEURONTIN (View Neurontin Review and Neurontin Label ), CYMBALTA (View Cymbalta Review and Cymbalta Label ).

5694744-1 | Gastric Ulcer
on Apr 03, 2008 Female patient from UNITED STATES , 90 years of age, weighting 89.95 lb, was diagnosed with cardiac disorder, arthritis (What is arthritis?) and was treated with Naprosyn (View Usage). Patient experienced the following unwanted or unexpected effects: gastric ulcer. Naprosyn dosage: 500mg Daily Po. During the same period patient was treated with ASPIRIN (81mg Daily Po) (View Aspirin Review and Aspirin Label ). Patient was hospitalized.

5694594-6 | Completed Suicide, Overdose
Patient was taking Naprosyn (View Usage). Patient had the following side effects: completed suicide, overdose on Sep 21, 2005 from UNITED KINGDOM Additional patient health information: Female patient , 37 years of age, was diagnosed with depression (What is depression?) and. Naprosyn dosage: . During the same period patient was treated with SEROXAT (View Seroxat Review and Seroxat Label ), ALCOHOL (View Alcohol Review and Alcohol Label ).